A presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.
CHAI DRV/r 2L Product Profile
Updated: Apr 1, 2022
A framework to support new product introduction in national health systems
Updated: Apr 1, 2022
A presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.
Comments